Targeting Sedentary Behavior in CKD A Pilot and Feasibility Randomized Controlled Trial

被引:16
|
作者
Lyden, Kate [1 ,2 ]
Boucher, Robert [3 ]
Wei, Guo [3 ,4 ]
Zhou, Na [3 ]
Christensen, Jesse [5 ]
Chertow, Glenn M. [6 ]
Greene, Tom [4 ]
Beddhu, Srinivasan [3 ,7 ]
机构
[1] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA
[2] Colorado State Univ, Dept Hlth & Exercise Sci, Ft Collins, CO 80523 USA
[3] Univ Utah, Sch Med, Div Nephrol & Hypertens, Suite 360,421 Wakara Way, Salt Lake City, UT 84108 USA
[4] Univ Utah, Sch Med, Div Biostat, Salt Lake City, UT USA
[5] Vet Affairs Salt Lake City Hlth Care Syst, Dept Phys Med & Rehabil, Salt Lake City, UT USA
[6] Stanford Univ, Div Nephrol, Palo Alto, CA 94304 USA
[7] Vet Affairs Salt Lake City Hlth Care Syst, Med Serv, Salt Lake City, UT USA
关键词
sedentary behavior; chronic kidney disease; behavioral intervention; CHRONIC KIDNEY-DISEASE; TELEVISION VIEWING TIME; AEROBIC EXERCISE; ACTIVITY-MONITOR; CARDIOVASCULAR-DISEASE; CARDIOMETABOLIC RISK; PHYSICAL-ACTIVITY; LIFE-STYLE; POPULATION; OBESITY;
D O I
10.2215/CJN.12300720
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives We tested the feasibility of reducing sedentary behavior common in CKD. Design, setting, participants, & measurements We carried out a Sit Less, Interact, Move More intervention in a 24-week parallel-group, randomized controlled trial in patients with stages 2-5 CKD. In the intervention group (n=54), accelerometry performed at baseline and repeated every 4 weeks was used to develop and monitor adherence to individualized plans targeting sedentary and stepping durations. The control group (n=52) was provided national physical activity recommendations; accelerometry was performed at baseline and every 8 weeks. Between-groups changes from baseline to the average follow-up values at weeks 8, 16, and 24 of the sedentary and stepping durations were the coprimary end points. Results The mean age was 69 +/- 13 years. Fourteen percent were on dialysis or received a kidney transplant. Eight percent of the control group and 17% of the intervention group were lost to follow-up. Sedentary and stepping durations did not change in the control group. Within the intervention group, the maximum decrease in sedentary duration (-43; 95% confidence interval, -69 to -17 min/d) and increase in stepping duration (16; 95% confidence interval, 7 to 24 min/d) and the number of steps per day (1265; 95% confidence interval, 518 to 2012) were seen at week 20. These attenuated at week 24. In mixed effects models, overall treatment effects between groups on sedentary (-17; 95% confidence interval, -43 to 8 min/d) and stepping (6; 95% confidence interval, -3 to 15 min/d) durations and the number of steps per day, a secondary end point (652; 95% confidence interval, -146 to 1449), were not significantly different. The intervention significantly reduced secondary end points of bodymass index (-1.1; 95% confidence interval, -1.9 to -0.3 kg/m(2)) and body fat percentage (-2.1%; 95% confidence interval, -4.4% to -0.2%). Conclusions It is feasible to reduce sedentary duration and increase stepping duration in patients with CKD, but these were not sustained.
引用
收藏
页码:717 / 726
页数:10
相关论文
共 50 条
  • [21] Cognitive behavior therapy for driving fear: A pilot randomized controlled trial
    Fischer, Carolin
    Heider, Jens
    Taylor, Joanne E.
    Schroeder, Annette
    TRANSPORTATION RESEARCH PART F-TRAFFIC PSYCHOLOGY AND BEHAVIOUR, 2021, 83 : 118 - 129
  • [22] REducing SEDENTary Behavior Among Mild to Moderate Cognitively Impaired Assisted Living Residents: A Pilot Randomized Controlled Trial (RESEDENT Study)
    Dillon, K.
    Prapavessis, Harry
    JOURNAL OF AGING AND PHYSICAL ACTIVITY, 2021, 29 (01) : 27 - 35
  • [23] Recruitment feasibility for a pilot randomized controlled trial on the effect of naturopathic therapies on estrogen metabolism
    Greenlee, H
    Gonzalez, AJ
    Lampe, JW
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (11) : 1302S - 1302S
  • [24] Stage 1 Treatment of Pediatric Overweight and Obesity: A Pilot and Feasibility Randomized Controlled Trial
    Stovitz, Steven D.
    Berge, Jerica M.
    Wetzsteon, Rachel J.
    Sherwood, Nancy E.
    Hannan, Peter J.
    Himes, John H.
    CHILDHOOD OBESITY, 2014, 10 (01) : 50 - 57
  • [25] Feasibility of using a biofeedback device in mindfulness training-a pilot randomized controlled trial
    Lin, Brenna
    Prickett, Christopher
    Woltering, Steven
    PILOT AND FEASIBILITY STUDIES, 2021, 7 (01)
  • [26] Reconstructing Meaning with Others in Loss: A Feasibility Pilot Randomized Controlled Trial of a Bereavement Group
    MacKinnon, Christopher J.
    Smith, Nathan Grant
    Henry, Melissa
    Milman, Evgenia
    Chochinov, Harvey M.
    Koerner, Annette
    Berish, Mel
    Farrace, Amanda Jessica
    Liarikos, Nikoleta
    Cohen, S. Robin
    DEATH STUDIES, 2015, 39 (07) : 411 - 421
  • [27] Feasibility and acceptability of a beverage intervention for Hispanic adults: a protocol for a pilot randomized controlled trial
    Kristin E. Morrill
    Benjamin Aceves
    Luis A. Valdez
    Cynthia A. Thomson
    Iman A. Hakim
    Melanie L. Bell
    Jessica A. Martinez
    David O. Garcia
    Nutrition Journal, 17
  • [28] A feasibility and pilot randomized controlled trial of the "Timing it Right Stroke Family Support Program"
    Cameron, Jill I.
    Naglie, Gary
    Green, Theresa L.
    Gignac, Monique A. M.
    Bayley, Mark
    Huijbregts, Maria
    Silver, Frank L.
    Czerwonka, Anna
    CLINICAL REHABILITATION, 2015, 29 (11) : 1129 - 1140
  • [29] Dynamic interpersonal therapy for moderate to severe depression: a pilot randomized controlled and feasibility trial
    Fonagy, Peter
    Lemma, Alessandra
    Target, Mary
    O'Keeffe, Sally
    Constantinou, Matthew P.
    Wurman, Tamara Ventura
    Luyten, Patrick
    Allison, Elizabeth
    Roth, Anthony
    Cape, John
    Pilling, Stephen
    PSYCHOLOGICAL MEDICINE, 2020, 50 (06) : 1010 - 1019
  • [30] Feasibility and Acceptability of Metformin to Augment Low Milk Supply: A Pilot Randomized Controlled Trial
    Nommsen-Rivers, Laurie
    Thompson, Amy
    Riddle, Sarah
    Ward, Laura
    Wagner, Erin
    King, Eileen
    JOURNAL OF HUMAN LACTATION, 2019, 35 (02) : 261 - 271